07:19 EST Olema Oncology (OLMA) up 13% at $11.40 after entering supply pact with Novartis
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLMA:
- Olema Oncology, Novartis enter clinical trial collaboration and supply agreement
- Olema Oncology reports Q3 EPS (60c), consensus (58c)
- OLMA Earnings this Week: How Will it Perform?
- Olema Oncology presents preclinical data on anti-tumor activity for OP-3136
- Olema Oncology to present multiple posters at EORTC-NCI-AACR